The market for disposable wireless Medical Body Area Network (MBAN) sensors within professional healthcare is in its earliest stages, but key foundations to support adoption are now in place. There is also tremendous potential for adoption. So much so that by 2018, close to 5 million disposable sensors will be shipped even though MBAN sensors will have still barely penetrated the addressable market.
Assurance Biosense, a subsidiary of Xhale, Inc., today announced that it will unveil its next-generation Assurance® Alar Sensor at the International Anesthesia Research Society (IARS) meeting in San Diego May 4-7, 2013.
Jawbone®, a leader and innovator in products and services for the way we live, today announced that it is acquiring BodyMedia® to further its leadership and accelerate its innovation in wearable health technology and personal data analysis.
Masimo announced today that its iSpO2™ pulse oximeter for iPad, iPhone, and iPod touch and EMMA™ Emergency Capnometer earned JEMS Hot Product awards. Only two companies received dual Hot Product award honors at the EMS Today 2013 Conference & Exposition, the industry's leading emergency medical services (EMS) event held recently in Washington, D.C.
A new 3-D motion detection system could help identify baseball pitchers who are at risk for shoulder injuries, according to a new study.
With the recent launch of MIT’s Institute for Medical Engineering and Science, MIT News examines research with the potential to reshape medicine and health care through new scientific knowledge, novel treatments and products, better management of medical data, and improvements in health-care delivery.
Researchers at the Optical Fibre Sensors Research Centre, University of Limerick have developed a technology to ensure improved safety and more effective treatment for patients undergoing radiotherapy.
Veredus Laboratories today announced that the current version of VereFlu detects the current subtype of H7N9 (Avian Flu) that is responsible for the Flu outbreak in China. H7N9 is the latest mutation to cause concern and increased surveillance in the region. Launched in 2008 and built on the STMicroelectronics lab-on-chip platform, VereFlu run on Veredus’ VerePLEXTM biosystem is the market’s first test to integrate two powerful molecular biological applications, Polymerase Chain Reaction (PCR) and a microarray, onto a Lab-on-Chip platform.
Terumo Cardiovascular Systems today announced that it has entered into a multi-year distribution agreement with Nonin Medical, Inc., a leader in noninvasive medical monitoring. Beginning May 1, 2013, Terumo CVS will distribute Nonin's EQUANOX™ Model 7600 Regional Oximetry System to adult and pediatric cardiovascular hospitals in the United States; Nonin's direct sales force will focus on certain non-cardiovascular applications in those hospitals, and applications in all other U.S. hospitals.
PCH International is delighted to announce a partnership with Irish company Zinc Software Limited as part of the PCH Accelerator program. The partnership will offer Zinc Software Ltd access to PCH's global product development and supply chain solutions that are used by the world's top brands.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.